XML 34 R20.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes
12 Months Ended
Dec. 31, 2022
Income Taxes  
Income Taxes

Note 14—Income Taxes

The components of income tax expense (benefit) from continuing and discontinued operations were as follows:

    

December 31, 

    

2022

    

2021

    

2020

(In thousands)

Continuing operations:

Current income tax expense:

  

 

  

 

  

Federal

$

$

$

State

 

 

 

Total current income tax expense

 

 

 

Deferred income tax benefit:

 

  

 

  

 

  

Federal

 

 

 

(19,472)

State

 

 

 

(3,784)

Total deferred income tax benefit

(23,256)

Income tax benefit in continuing operations

$

$

$

(23,256)

Income tax expense as a component of discontinued operations

$

3,952

$

1,006

$

11,245

In 2022 and 2021, for federal and state income tax purposes, we had net losses from continuing operations and net income from discontinued operations, which resulted in overall taxable net income. For federal income tax purposes, we utilized existing net operating loss carryforwards of $269.8 million and $245.1 million respectively to fully offset our federal tax liability for both periods. For state income tax purposes, we did not have adequate net operating losses and tax credits to fully offset our state tax liability. We recorded a state income tax expense of $4.0 million and $1.0 million in discontinued operations in 2022 and 2021, respectively. As of December 31, 2022, income taxes payable of $4.9 million is included in accrued expenses in our consolidated balance sheet.

In 2020, we adopted ASU 2019-12, Income Taxes (Topic 740), which eliminated the exception to the incremental approach of intra-period tax allocation whereby losses from continuing operations can no longer offset income from discontinued operations. This resulted in an income tax benefit of $23.3 million in continuing operations and income tax expense of $11.2 million in discontinued operations in 2020.

Deferred income taxes reflect the tax effect of net operating loss and tax credit carryforwards and the net temporary difference between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

Significant components of deferred income taxes were as follows:

    

December 31, 

    

2022

    

2021

(In thousands)

Deferred tax assets:

  

 

  

Net operating loss carryforwards

$

85,887

$

143,657

Research and development tax credits

 

78,992

 

66,612

OMIDRIA royalty obligation

28,938

Capitalized research and development

21,864

Stock-based compensation

 

12,517

 

11,327

Lease liability

 

5,926

 

9,995

Other

 

9,234

 

17,862

Total deferred tax assets

 

243,358

 

249,453

Deferred tax liabilities:

 

  

 

  

Gain on discontinued operations

(34,883)

(42,212)

Right of use assets

(4,987)

(6,467)

Property and equipment

(288)

(102)

Total deferred tax liabilities

 

(40,158)

 

(48,781)

Net deferred tax assets before valuation allowance

 

203,200

 

200,672

Less valuation allowance

 

(203,200)

 

(201,340)

Net deferred tax liabilities

$

$

(668)

As of December 31, 2022, we had federal net operating loss carryforwards of approximately $361.0 million and state net operating loss carryforwards of approximately $220.0 million. Pre-2018 federal net operating losses of $109.4 million expire between 2035 and 2037. Post-2018 federal net operating losses of $251.6 million do not expire. Research and development tax credit carryforwards of $79.2 million expire between 2023 and 2042.

The Tax Cuts and Jobs Act was enacted on December 22, 2017 and requires the capitalization and subsequent amortization of research and experimental expenditures beginning in 2022. During 2022, we capitalized $21.9 million of research and development expenses into deferred tax assets. Prior to 2022, these costs were expensed as incurred for tax purposes.

We established a 100% valuation allowance for all periods due to the uncertainty around our ability to generate sufficient taxable income to realize our deferred tax assets. During 2022 and 2021, respectively, our valuation allowance decreased $1.9 million and $19.3 million.

Reconciliation of income tax computed at federal statutory rates to the reported provisions for income taxes from continuing operations are as follows:

    

Year ended December 31, 

 

    

2022

    

2021

    

2020

 

U.S. Federal statutory rate on net loss

(21.0)

%  

(21.0)

%  

(21.0)

%  

State tax, net of federal tax benefit

(1.7)

%  

(0.6)

%  

(3.1)

%  

Change in valuation allowance

28.3

%  

26.9

%  

19.3

%  

Research and development tax credits

(6.8)

%  

(5.5)

%  

(6.2)

%  

Stock compensation

1.4

%  

0.3

%  

0.5

%  

Other

(0.2)

%  

(0.1)

%  

(1.3)

%  

Effective tax rate

(0.0)

%  

(0.0)

%  

(11.8)

%

We file federal and certain state income tax returns, which provides varying statutes of limitations on assessments. However, because of net operating loss carryforwards, substantially all our tax years remain open to federal and state tax examination.

We recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense. To date, there have been no significant interest or penalties charged to us in relation to the underpayment of income taxes.